Source: Cancer Research. Conference titles: AACR Annual Meeting. Unidade: FMRP
Subjects: BETA-BLOQUEADORES, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS, ADRENORECEPTORES, NEOPLASIA ENDÓCRINA MÚLTIPLA, METÁSTASE NEOPLÁSICA
ABNT
MARIA, Andrea G. et al. Blockade of beta-catenin pathway combined with Aurora kinase activity inhibition enhances antitumor effects in adrenocortical cancer cells. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-412. Acesso em: 04 maio 2026. , 2021APA
Maria, A. G., Borges, K. S., Lira, R. C., Thome, C. H., Berthon, A., Drougat, L., et al. (2021). Blockade of beta-catenin pathway combined with Aurora kinase activity inhibition enhances antitumor effects in adrenocortical cancer cells. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-412NLM
Maria AG, Borges KS, Lira RC, Thome CH, Berthon A, Drougat L, Faucz FR, Faça VM, Tone LG, Stratakis CA. Blockade of beta-catenin pathway combined with Aurora kinase activity inhibition enhances antitumor effects in adrenocortical cancer cells [Internet]. Cancer Research. 2021 ; 81[citado 2026 maio 04 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-412Vancouver
Maria AG, Borges KS, Lira RC, Thome CH, Berthon A, Drougat L, Faucz FR, Faça VM, Tone LG, Stratakis CA. Blockade of beta-catenin pathway combined with Aurora kinase activity inhibition enhances antitumor effects in adrenocortical cancer cells [Internet]. Cancer Research. 2021 ; 81[citado 2026 maio 04 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-412
